Literature DB >> 22609205

Blockade of β-cell K(ATP) channels by the endocannabinoid, 2-arachidonoylglycerol.

Charles E Spivak1, Wook Kim, Qing-Rong Liu, Carl R Lupica, Máire E Doyle.   

Abstract

The endocannabinoid system has been demonstrated to be active in the pancreatic β-cell. However the effects of the endocannabinoids (ECs) on insulin secretion are not well defined and may vary depending on the metabolic state of the β-cell. Specifically it is not known whether the effects of the ECs occur by activation of the cannabinoid receptors or via their direct interaction with the ion channels of the β-cell. To begin to delineate the effects of ECs on β-cell function, we examined how the EC, 2-AG influences β-cell ion channels in the absence of glucose stimulation. The mouse insulinoma cell line R7T1 was used to survey the effects of 2-AG on the high voltage activated (HVA) calcium, the delayed rectifier (K(v)), and the ATP-sensitive K (K(ATP)) channels by whole cell patch clamp recording. At 2mM glucose, 2-AG inhibited the HVA calcium (the majority of which are L-type channels), K(v), and K(ATP) channels. The channel exhibiting the most sensitivity to 2-AG blockade was the K(ATP) channel, where the IC(50) for 2-AG was 1 μM. Pharmacological agents revealed that the blockade of all these channels was independent of cannabinoid receptors. Our results provide a mechanism for the previous observations that CB1R agonists increase insulin secretion at low glucose concentrations through CB1R independent blockade of the K(ATP) channel.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22609205      PMCID: PMC3417811          DOI: 10.1016/j.bbrc.2012.05.042

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

Review 1.  The molecular logic of endocannabinoid signalling.

Authors:  Daniele Piomelli
Journal:  Nat Rev Neurosci       Date:  2003-11       Impact factor: 34.870

Review 2.  The endocannabinoid system and its therapeutic exploitation.

Authors:  Vincenzo Di Marzo; Maurizio Bifulco; Luciano De Petrocellis
Journal:  Nat Rev Drug Discov       Date:  2004-09       Impact factor: 84.694

3.  Effects of anandamide and arachidonic acid on specific binding of (+) -PN200-110, diltiazem and (-) -desmethoxyverapamil to L-type Ca2+ channel.

Authors:  K Shimasue; T Urushidani; M Hagiwara; T Nagao
Journal:  Eur J Pharmacol       Date:  1996-02-05       Impact factor: 4.432

Review 4.  Adenosine 5'-triphosphate-sensitive potassium channels.

Authors:  F M Ashcroft
Journal:  Annu Rev Neurosci       Date:  1988       Impact factor: 12.449

5.  The distribution of numbers of open channels in multi-channel patches.

Authors:  C A Glasbey; R J Martin
Journal:  J Neurosci Methods       Date:  1988-07       Impact factor: 2.390

Review 6.  International Union of Pharmacology. XXVII. Classification of cannabinoid receptors.

Authors:  A C Howlett; F Barth; T I Bonner; G Cabral; P Casellas; W A Devane; C C Felder; M Herkenham; K Mackie; B R Martin; R Mechoulam; R G Pertwee
Journal:  Pharmacol Rev       Date:  2002-06       Impact factor: 25.468

7.  Isolation, identification and synthesis of an endogenous arachidonic amide that inhibits calcium channel antagonist 1,4-dihydropyridine binding.

Authors:  D E Johnson; S L Heald; R D Dally; R A Janis
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1993-06       Impact factor: 4.006

8.  Differential effects of endogenous and synthetic cannabinoids on voltage-dependent calcium fluxes in rabbit T-tubule membranes: comparison with fatty acids.

Authors:  Murat Oz; Yulia Tchugunova; Meral Dinc
Journal:  Eur J Pharmacol       Date:  2004-10-11       Impact factor: 4.432

9.  Conformationally restrained analogues of pravadoline: nanomolar potent, enantioselective, (aminoalkyl)indole agonists of the cannabinoid receptor.

Authors:  T E D'Ambra; K G Estep; M R Bell; M A Eissenstat; K A Josef; S J Ward; D A Haycock; E R Baizman; F M Casiano; N C Beglin
Journal:  J Med Chem       Date:  1992-01       Impact factor: 7.446

10.  Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.

Authors:  R Mechoulam; S Ben-Shabat; L Hanus; M Ligumsky; N E Kaminski; A R Schatz; A Gopher; S Almog; B R Martin; D R Compton
Journal:  Biochem Pharmacol       Date:  1995-06-29       Impact factor: 5.858

View more
  5 in total

Review 1.  Why do cannabinoid receptors have more than one endogenous ligand?

Authors:  Vincenzo Di Marzo; Luciano De Petrocellis
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-12-05       Impact factor: 6.237

Review 2.  Endocannabinoid regulation of β-cell functions: implications for glycaemic control and diabetes.

Authors:  T Jourdan; G Godlewski; G Kunos
Journal:  Diabetes Obes Metab       Date:  2016-03-31       Impact factor: 6.577

Review 3.  Cannabis and Cannabinoids in Reproduction and Fertility: Where We Stand.

Authors:  Bruno M Fonseca; Irene Rebelo
Journal:  Reprod Sci       Date:  2021-05-10       Impact factor: 2.924

4.  Cannabinoid receptors are differentially regulated in the pancreatic islets during the early development of metabolic syndrome.

Authors:  Antonio Barajas-Martínez; Karina Bermeo; Lizbeth de la Cruz; Marina Martínez-Vargas; Ricardo Jesús Martínez-Tapia; David Erasmo García; Luz Navarro
Journal:  Islets       Date:  2020-12-08       Impact factor: 2.694

5.  Potassium channels as molecular targets of endocannabinoids.

Authors:  Yu-Fung Lin
Journal:  Channels (Austin)       Date:  2021-12       Impact factor: 2.581

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.